PT Medikaloka Hermina Tbk
IDX:HEAL.JK
1450 (IDR) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,784,086 | 4,901,810 | 5,820,123 | 4,416,042 | 3,630,940 | 3,058,091 | 2,678,197 | 2,234,263 | 1,709,020 |
| Cost of Revenue
| 3,959,847 | 3,193,422 | 2,924,631 | 2,281,499 | 2,004,685 | 1,704,483 | 1,509,335 | 1,244,760 | 970,348 |
| Gross Profit
| 1,824,239 | 1,708,388 | 2,895,492 | 2,134,543 | 1,626,255 | 1,353,608 | 1,168,862 | 989,503 | 738,672 |
| Gross Profit Ratio
| 0.315 | 0.349 | 0.497 | 0.483 | 0.448 | 0.443 | 0.436 | 0.443 | 0.432 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 141,379 | 210,406 | 208,229 | 247,256 | 169,972 | 148,621 | 183,122 | 169,877 | 132,841 |
| Selling & Marketing Expenses
| 14,725 | 18,628 | 13,130 | 10,996 | 17,950 | 20,070 | 15,054 | 17,398 | 10,244 |
| SG&A
| 1,043,540 | 229,034 | 221,359 | 258,252 | 187,922 | 168,691 | 198,176 | 187,275 | 143,085 |
| Other Expenses
| 36,771 | 962,998 | 1,036,600 | 906,094 | 886,146 | 26,798 | 9,857 | 23,775 | 7,427 |
| Operating Expenses
| 1,043,540 | 1,192,032 | 1,257,959 | 1,164,346 | 1,074,068 | 990,031 | 782,599 | 677,999 | 509,725 |
| Operating Income
| 780,699 | 587,373 | 1,778,166 | 1,041,936 | 583,333 | 385,974 | 385,564 | 343,350 | 212,733 |
| Operating Income Ratio
| 0.135 | 0.12 | 0.306 | 0.236 | 0.161 | 0.126 | 0.144 | 0.154 | 0.124 |
| Total Other Income Expenses Net
| -70,306 | -107,285 | -119,964 | -95,926 | -77,857 | -88,039 | -107,256 | -29,698 | -46,436 |
| Income Before Tax
| 710,393 | 480,088 | 1,658,202 | 946,010 | 505,476 | 275,538 | 279,007 | 281,806 | 182,511 |
| Income Before Tax Ratio
| 0.123 | 0.098 | 0.285 | 0.214 | 0.139 | 0.09 | 0.104 | 0.126 | 0.107 |
| Income Tax Expense
| 151,109 | 101,315 | 358,428 | 300,372 | 161,556 | 84,514 | 105,372 | 82,672 | 57,591 |
| Net Income
| 437,346 | 298,596 | 995,974 | 645,638 | 343,920 | 124,374 | 97,549 | 61,996 | 19,298 |
| Net Income Ratio
| 0.076 | 0.061 | 0.171 | 0.146 | 0.095 | 0.041 | 0.036 | 0.028 | 0.011 |
| EPS
| 30.16 | 20.64 | 67.73 | 43.54 | 23.14 | 8.86 | 7.72 | 4.31 | 1.34 |
| EPS Diluted
| 29.73 | 20.57 | 66.8 | 43.37 | 22.79 | 8.86 | 7.72 | 4.31 | 1.34 |
| EBITDA
| 1,515,169 | 745,301 | 1,896,233 | 1,135,767 | 693,316 | 534,014 | 510,496 | 433,357 | 296,764 |
| EBITDA Ratio
| 0.262 | 0.152 | 0.326 | 0.257 | 0.191 | 0.175 | 0.191 | 0.194 | 0.174 |